What do Analysts Say about TherapeuticsMD, Inc.(NASDAQ:TXMD): Open Text Corporation(NASDAQ:OTEX)

0
2

TherapeuticsMD, Inc. (TXMD) will report its next earnings on Aug 05 AMC. The company reported the earnings of $-0.16/Share in the last quarter where the estimated EPS by analysts was $-0.17/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 5.9%.

Many analysts are providing their Estimated Earnings analysis for TherapeuticsMD, Inc. and for the current quarter 7 analysts have projected that the stock could give an Average Earnings estimate of $-0.17/share. These analysts have also projected a Low Estimate of $-0.21/share and a High Estimate of $-0.14/share.

In case of Revenue Estimates, 7 analysts have provided their consensus Average Revenue Estimates for TherapeuticsMD, Inc. as 5.58 Million. According to these analysts, the Low Revenue Estimate for TherapeuticsMD, Inc. is 4.73 Million and the High Revenue Estimate is 8.2 Million. The company had Year Ago Sales of 3.76 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for TXMD to be -13.3%. They are projecting Next Quarter growth of -6.25%. For the next 5 years, TherapeuticsMD, Inc. is expecting Growth of 50.89% per annum, whereas in the past 5 years the growth was -13.56% per annum.

Some buy side analysts are also providing their Analysis on TherapeuticsMD, Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for TherapeuticsMD, Inc. might touch $20 high while the Average Price Target and Low price Target is $10.71 and $4 respectively.

TherapeuticsMD, Inc. closed its last trading session at $2.6 with the loss of -1.54%. The Market Capitalization of the company stands at 596.17 Million. The Company has 52-week high of $6.94 and 52-week low of $2.21. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -0.37% where SMA50 and SMA200 are -17.74% and -44.26% respectively. The Company Touched its 52-Week High on 09/21/18 and 52-Week Low on 06/11/19.

The Relative Volume of the company is 0.59 and Average Volume (3 months) is 3.69 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -73.6%. The Return on Equity (ROE) value stands at -159.7%. While it’s Return on Investment (ROI) value is -76.2%.

While looking at the Stock’s Performance, TherapeuticsMD, Inc. currently shows a Weekly Performance of 0%, where Monthly Performance is -14.95%, Quarterly performance is -46.78%, 6 Months performance is -43.11% and yearly performance percentage is -61.15%. Year to Date performance value (YTD perf) value is -32.81%. The Stock currently has a Weekly Volatility of 6.04% and Monthly Volatility of 8.77%.

Open Text Corporation (OTEX) will report its next earnings on Jul 31 AMC. The company reported the earnings of $0.64/Share in the last quarter where the estimated EPS by analysts was $0.6/share. The difference between the expected and actual EPS was $0.04/share, which represents an Earnings surprise of 6.7%.

Many analysts are providing their Estimated Earnings analysis for Open Text Corporation and for the current quarter 11 analysts have projected that the stock could give an Average Earnings estimate of $0.72/share. These analysts have also projected a Low Estimate of $0.66/share and a High Estimate of $0.75/share.

In case of Revenue Estimates, 7 analysts have provided their consensus Average Revenue Estimates for Open Text Corporation as 764.47 Million. According to these analysts, the Low Revenue Estimate for Open Text Corporation is 751.76 Million and the High Revenue Estimate is 773 Million. The company had Year Ago Sales of 754.27 Million.

Some buy side analysts are also providing their Analysis on Open Text Corporation, where 5 analysts have rated the stock as Strong buy, 3 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Open Text Corporation might touch $50 high while the Average Price Target and Low price Target is $45.42 and $38 respectively.

Open Text Corporation closed its last trading session at $42.45 with the gain of 0.26%. The Market Capitalization of the company stands at 11.48 Billion. The Company has 52-week high of $42.88 and 52-week low of $30.99. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 2.7% where SMA50 and SMA200 are 4.84% and 15.26% respectively. The Company Touched its 52-Week High on 07/10/19 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 1.48 and Average Volume (3 months) is 632.46 million. The company’s P/E (price to earnings) ratio is 41.81 and Forward P/E ratio of 14.32.

The company shows its Return on Assets (ROA) value of 3.6%. The Return on Equity (ROE) value stands at 7.3%. While it’s Return on Investment (ROI) value is 6.1%.

While looking at the Stock’s Performance, Open Text Corporation currently shows a Weekly Performance of 1.62%, where Monthly Performance is 3.1%, Quarterly performance is 10.34%, 6 Months performance is 26.25% and yearly performance percentage is 15.15%. Year to Date performance value (YTD perf) value is 30.55%. The Stock currently has a Weekly Volatility of 1.67% and Monthly Volatility of 1.48%.

SHARE